Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1.25 NOK
Change Today +0.08 / 6.84%
Volume 560.0K
BIONOR On Other Exchanges
As of 10:25 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard B. Pollard M.D.

Member of Clinical Advisory Board,Bionor Pharma ASA
AgeTotal Calculated CompensationThis person is connected to 66 board members in 3 different organizations across 4 different industries.

See Board Relationships


Dr. Richard B. Pollard, M.D., has been Chief Medical officer of Genetic Immunity, LLC since December 2007. Dr. Pollard has been Chief of Division for Infectious Diseases at the University of California since 2002 and serves as its Professor of Internal Medicine and Microbiology. Dr Pollard’s research interests are focused on the pathogenesis of HIV infection and complicating viruses. He is a Principal Investigator of the California Research Center for the Biology of ...

Read Full Background

Corporate Headquarters*

Kronprinsesse Märthas plass 1
Oslo, Oslo 0116


Phone: 47 23 01 09 60
Fax: 47 23 01 09 70

Board Members Memberships*

There is no Board Members Memberships data available.


Unknown/Other Education 1975
Emory University
Unknown/Other Education
University of Maryland

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIONOR:NO 1.25 NOK +0.08


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIONOR PHARMA ASA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at